Transcription inhibitors and inflammatory cell activity.

Transcription inhibitors and inflammatory cell activity. Curr Opin Pharmacol. 2019 Jun 14;46:82-89 Authors: Caramori G, Coppolino I, Cannavò MF, Nucera F, Proietto A, Mumby S, Ruggeri P, Adcock IM Abstract Inflammation is a central feature of asthma and chronic obstructive pulmonary disease (COPD). Despite recent advances in the knowledge of the pathogenesis of asthma and COPD, much more research on the molecular mechanisms of asthma and COPD are needed to aid the logical development of new therapies for these common and important diseases, particularly in COPD where no new effective treatments currently exist. In the future the role of the activation/repression of different transcription factors and the genetic regulation of their expression in asthma and COPD may be an increasingly important aspect of research, as this may be one of the critical mechanisms regulating the expression of different clinical phenotypes and their responsiveness to therapy, particularly to anti-inflammatory drugs. PMID: 31207387 [PubMed - as supplied by publisher]
Source: Current Opinion in Pharmacology - Category: Drugs & Pharmacology Authors: Tags: Curr Opin Pharmacol Source Type: research